Lauren Sabella
2013
In 2013, Lauren Sabella earned a total compensation of $1.3M as Chief Commercial Officer at Acorda Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $131,535 |
|---|---|
| Option Awards | $623,687 |
| Salary | $352,967 |
| Stock Awards | $216,266 |
| Other | $7,650 |
| Total | $1,332,105 |
Sabella received $623.7K in option awards, accounting for 47% of the total pay in 2013.
Sabella also received $131.5K in non-equity incentive plan, $353K in salary, $216.3K in stock awards and $7.7K in other compensation.
Rankings
In 2013, Lauren Sabella's compensation ranked 5,418th out of 12,286 executives tracked by ExecPay. In other words, Sabella earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,418 out of 12,286 | 56th |
Division Manufacturing | 1,883 out of 4,612 | 59th |
Major group Chemicals And Allied Products | 543 out of 1,462 | 63rd |
Industry group Drugs | 386 out of 1,156 | 67th |
Industry Biological Products, Except Diagnostic Substances | 59 out of 196 | 70th |
Source: SEC filing on April 29, 2016.
Sabella's colleagues
We found six more compensation records of executives who worked with Lauren Sabella at Acorda Therapeutics in 2013.
2013
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2013
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2013
Jane Wasman
Acorda Therapeutics
General Counsel
2013
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2013
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2013
David Lawrence
Acorda Therapeutics
Chief Financial Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019